Back to today’s briefing

Story perspectives

Australia Faces Severe ADHD Medication Shortage Until 2025

4/11/2025

35 3

Summary

Story summary

Australia is grappling with a severe shortage of ADHD medications, especially Ritalin and Artige tablets, stemming from manufacturing problems. With 413 shortages reported by the Therapeutic Goods Administration (TGA) and 80 more anticipated, patients are advised to prepare for potential disruptions lasting until late 2025. While alternative treatments exist, prescribers face the daunting task of navigating these challenges.

1 of 1

Story summary

Australia is grappling with a severe shortage of ADHD medications, especially Ritalin and Artige tablets, stemming from manufacturing problems. With 413 shortages reported by the Therapeutic Goods Administration (TGA) and 80 more anticipated, patients are advised to prepare for potential disruptions lasting until late 2025. While alternative treatments exist, prescribers face the daunting task of navigating these challenges.